Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 8Unknown 4Withdrawn 2Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 1324Neoplasms 982Carcinoma, Non-Small-Cell Lung 860Prostatic Neoplasms 724Colorectal Neoplasms 666Lung Neoplasms 551Leukemia, Myeloid, Acute 475Neoplasm Metastasis 434Pancreatic Neoplasms 419Carcinoma, Hepatocellular 407Multiple Myeloma 396Ovarian Neoplasms 392Stomach Neoplasms 379Recurrence 364Squamous Cell Carcinoma of Head and Neck 325Melanoma 294Brain Neoplasms 287Uterine Cervical Neoplasms 283Triple Negative Breast Neoplasms 271Glioblastoma 264Head and Neck Neoplasms 263Precursor Cell Lymphoblastic Leukemia-Lymphoma 254Endometrial Neoplasms 234Lymphoma 228Rectal Neoplasms 222Esophageal Neoplasms 222Sarcoma 213Carcinoma, Renal Cell 203Colonic Neoplasms 194Lymphoma, Non-Hodgkin 191

Interventions

Thyroxine 1Antithyroid Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Hypothyroidism × Clear all
NCT06455371 2025-09-10

Patient-centered Dosage of Levothyroxine

University Hospital of North Norway

Phase NA Recruiting
240 enrolled
Head & Neck

Hypothyroidism, Thyroid Diseases, Thyroid Neoplasms

NCT05316922 2023-12-06

WIN-HYPO2021

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 3 Recruiting
68 enrolled
Head & Neck

Hypothyroidism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡